Emulating the PIONEER6 Diabetes Trial Using Healthcare Claims

CompletedOBSERVATIONAL

Enrollment

26,126

Participants

Timeline

Start Date

October 24, 2024

Primary Completion Date

March 6, 2025

Study Completion Date

March 6, 2025

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

New use of oral semaglutide

New use of oral semaglutide dispensing claim is used as the exposure.

DRUG

New initiation of sitagliptin

New use of sitagliptin dispensing claim is used as the reference.

Trial Locations (1)

Brigham and Women's Hospital, Boston

All Listed Sponsors

lead

Brigham and Women's Hospital

OTHER

NCT06659679 - Emulating the PIONEER6 Diabetes Trial Using Healthcare Claims | Biotech Hunter | Biotech Hunter